Unlock instant, AI-driven research and patent intelligence for your innovation.
Pharmaceutical composition for treating cervix uteri postoperative bleeding
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the direction of drug combination, blood disease, medical formula, etc., can solve the problems of easily damaged mucosal tissue, massive bleeding, unsatisfactory, etc., to help self-recovery, reduce irritation, and unique formula Effect
Inactive Publication Date: 2013-12-04
岳本兰
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0003] Cervical bleeding after cervical surgery is different from bleeding in other parts of the body. It cannot be bandaged to stop bleeding. Compression to stop bleeding can easily damage the mucosal tissue, and excessive pressure will also affect local blood supply and delay healing.
[0004] The current treatment mostly uses gauze packing with drugs, such as silver nitrate, hemostatic powder, etc. However, the above methods are not ideal for the intractable bleeding in the dementia period after cervical electric ironing or microwave surgery, and individual cases are often hospitalized for massive bleeding
And silver nitrate, hemostatic powder, etc. can not improve the symptoms of increased vaginal discharge irritating
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0022] Example 1, the weight ratio of raw materials: Buglossia 6g, Elaeagnus sativa bark 8g, Huanghuamu 8g, Kudiezi 6g, Radix Paeoniae Alba 6g, Citrus aurantium 8g, rose 6g, tangerine peel 8g, Cyperus cyperi 3g.
Embodiment 2
[0023] Example 2, the weight ratio of raw materials: Buglossia 10g, Elaeagnus sativa bark 15g, Huanghuamu 15g, Kudiezi 10g, Radix Paeoniae Alba 10g, Citrus aurantium 15g, rose 10g, tangerine peel 15g, Cyperus 6g.
Embodiment 3
[0024] Example 3, the weight ratio of raw materials: Buglossia 8g, Elaeagnus sativa bark 10g, Huanghuamu 10g, Kudiezi 8g, Radix Paeoniae Alba 8g, Citrus aurantium 10g, rose 8g, tangerine peel 10g, Cyperus cyperi 5g.
[0025] When in use, add water to decoct the traditional Chinese medicine Buglossae, Elaeagnus sativa, Fructus Chrysantha, Kudiezi, Radix Paeoniae Alba, Fructus Citrus Citrii Fructus, Rose, Rhizoma Rhizoma Cyperi and Tangerine Peel twice, and combine the filtrates.
[0026] The filtrate can be soaked into gauze for local packing, and it can also be taken orally because of its mild medicinal properties.
[0027] The effective combination and coordination of the above pharmaceutical compositions can effectively achieve the purpose of treating postoperative bleeding of the cervix with less side effects.
[0028] The above-mentioned results are fully proved by the clinical data, and the relevant data are as follows, wherein the drug composition used for research is th...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a pharmaceutical composition for treating cervix uteri postoperative bleeding in order to solve the treatment problem of cervix uteri postoperative bleeding. The pharmaceutical composition is characterized by being processed from a plurality of Chinese medicinal herbs; and the raw material formula and the weight proportion are as follows: 6-10 parts of oxtongue, 8-15 parts of desert date bark, 8-15 parts of broomjutre sida herb, 6-10 parts of sowthistle-leaf ixeris seedling, 6-10 parts of radix paeoniae alba, 8-15 parts of immature bitter orange, 6-10 parts of rose, 8-15 parts of dried tangerine or orange peel and 3-6 parts of rhizoma cyperi. According to clinical trials, the pharmaceutical composition disclosed by the invention has the following characteristics of excellent treatment effect and higher security in the treatment of cervix uteri postoperative bleeding, so that the pharmaceutical composition is worthy of being applied and popularized.
Description
technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating postoperative bleeding of the cervix. Background technique [0002] For those with benign uterine diseases limited to the cervix but not to the uterine body, cervical surgery can be performed through the vagina, such as cervical polyp removal, cervical biopsy, cervical ironing and microwave treatment for chronic cervicitis, etc. [0003] Cervical bleeding after cervical surgery is different from bleeding in other parts of the body. It cannot be bandaged to stop bleeding. Compression to stop bleeding can easily damage the mucosal tissue, and excessive pressure will also affect local blood supply and delay healing. [0004] The current treatment mostly uses gauze packing with drugs, such as silver nitrate, hemostatic powder, etc. However, the above methods are not ideal for the intractable bleeding in the dementia period after ce...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More